However, in N1 stage patients a lower TZAP expression was associated with a poorer survival, which is consistent with the previous hypothesis that an insufficient TZAP expression could generate long telomeres, thus inducing cancer progression via immortal cells [7,15,16]. This evidence concerns the gene ZBTB48 and cancer.